"Combining CRISPR and transposon-based technologies for improved CAR-T therapies"

Learn how to use MaxCyte’s scalable transfection platforms to engineer primary cells while maintaining high efficiency and viability regardless of application in this session: "Combining CRISPR and transposon-based technologies for improved CAR-T therapies".

Speakers:

• Juan Roberto Rodriguez Madoz, Ph.D., Researcher at CIMA y Clínica Universidad de Navarra
• Alicia R. Merino, Ph.D., Senior Field Application Scientist, MaxCyte, Inc.
• Anna Otal Navarro, Business Development manager, MaxCyte, Inc.

⏰  2.30 pm

📍 Cima´s Main Hall

Registration is required.